ACTINIUM PHARMACEUTICALS INC - COM (ATNM) Institutional Ownership

13F Institutional Holders and Ownership History from Q2 2014 to Q3 2020

Type / Class
Equity / COM
Symbol
ATNM on NYSE
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Institutional Holders of ACTINIUM PHARMACEUTICALS INC - COM (ATNM) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2020 Q3 0 $0 -$30,487,000 0
2020 Q2 86,788,549 $30,511,000 +$26,619,267 $0.35 50
2020 Q1 10,687,614 $2,075,000 -$641,188 $0.20 32
2019 Q4 14,070,012 $3,062,000 -$2,439,500 $0.22 36
2019 Q3 24,948,557 $5,735,000 +$369,589 $0.23 35
2019 Q2 23,245,921 $5,718,000 +$3,510,645 $0.25 38
2019 Q1 8,833,329 $4,226,000 +$25,240 $0.48 40
2018 Q4 8,820,691 $3,422,000 -$890,413 $0.39 38
2018 Q3 9,590,037 $7,111,000 -$795,877 $0.74 39
2018 Q2 10,864,164 $6,953,000 -$4,060,996 $0.64 40
2018 Q1 22,526,710 $8,223,000 +$4,689,851 $0.37 35
2017 Q4 9,630,462 $6,391,000 -$2,543,873 $0.66 25
2017 Q3 14,188,770 $8,157,000 +$5,972,907 $0.57 29
2017 Q2 4,211,349 $5,136,000 +$545,674 $1.22 25
2017 Q1 3,741,036 $5,648,000 -$370,717 $1.51 27
2016 Q4 5,737,744 $5,021,000 -$452,184 $0.87 30
2016 Q3 6,242,960 $8,428,000 +$4,036,243 $1.35 29
2016 Q2 3,200,203 $5,660,000 +$751,225 $1.77 26
2016 Q1 2,764,230 $5,504,000 +$466,334 $1.99 28
2015 Q4 2,522,526 $8,122,000 +$934,443 $3.22 24
2015 Q3 2,448,914 $4,333,000 -$404,250 $1.77 26
2015 Q2 2,501,778 $6,628,915 -$1,979,311 $2.65 38
2015 Q1 3,247,606 $8,018,711 +$989,986 $2.47 38
2014 Q4 2,715,128 $15,972,590 -$210,302 $5.89 36
2014 Q3 2,704,911 $18,122,025 +$2,997,671 $6.70 31
2014 Q2 2,256,641 $16,293,542 +$16,281,543 $7.22 27